Casey Woodring
JPMorgan Chase & Co, Research Division
All right. Great. Thank you for joining us, everybody. I’m Casey Woodring from the Life Science Tools team here at JPMorgan. Welcome to our Healthcare Conference. Pleased to be joined by the management team of Mettler-Toledo. We’ll do the standard 40-minute presentation slot. Patrick will go through the corporate presentation, then we’ll do time for Q&A at the end. Patrick, go ahead.
Patrick Kaltenbach
President & CEO
Yes. Thank you, Casey, and good afternoon to everyone in the room and those joining us on the webcast. Thank you for being here today.
Similar to the past, I’d like to start off by providing an overview of the business, our competitive advantages, a review of our growth strategies and why we are well positioned to deliver excellent shareholder returns going forward. Before we get started, please notice our disclosure regarding forward-looking statements in the slides.
To start off, for those of you that are not familiar with our company, Mettler-Toledo is a global market leader in precision instrument measure — in precision measurement instruments used in laboratory and industrial applications around the world. We generated about $4 billion in revenue, and a significant majority of our sales are in segments in which we are a #1 global market share position.
Our business is very diversified in terms of the products we sell throughout our customers’ value chain and the end markets and geographic markets that we serve. The fragmentation and diversity business provides significant opportunity for growth and market share expansion.
